Basic Research
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 14, 2006; 12(42): 6835-6841
Published online Nov 14, 2006. doi: 10.3748/wjg.v12.i42.6835
Table 1 Liver biochemical tests and relative liver and spleen weights of rats at the end of 4th wk of bile duct obstruction (mean ± SE)
parameterVit CVit EVit ECShamControl
AST (IU/L)548 ± 82446 ± 75b505 ± 58a223 ± 26473 ± 64a
ALT (IU/L)156 ± 34148 ± 16156 ± 2398 ± 9165 ± 29
ALP (IU/L)446 ± 95403 ± 41396 ± 27296 ± 35477 ± 59
GGT (IU/L)64 ± 1386 ± 574 ± 864 ± 4101 ± 17
Total bilirubin (mg/dL)5.9 ± 1.2d7.2 ± 0.9d7.1 ± 1.3d0.5 ± 0.28.4 ± 1.4d
Conjugated bilirubin (mg/dL)3.9 ± 0.6d3.7 ± 1.0d3.5 ± 0.6d0.2 ± 0.14.2 ± 0.7d
Albumin (g/dL)3.2 ± 0.1b3.0 ± 0.1a3.3 ± 0.23.8 ± 0.02.9 ± 0.1d
Relative liver weight (%)5.9 ± 0.4a5.6 ± 0.6a5.9 ± 0.5b3.4 ± 0.65.9 ± 0.1d
Relative spleen weight (%)0.40 ± 0.070.39 ± 0.080.42 ± 0.080.34 ± 0.040.44 ± 0.05
Table 2 Serum hyaluronate levels, liver collagen content by biochemical method and collagen surface density by image analysis of groups at the end of 4th wk of study (mean ± SE)
parameterVit CVit EVit ECShamControl
Liver collagen content microgram collagen/mg protein32.7 ± 1.2bd33.8 ± 2.9bd36.7 ± 0.5ad23.8 ± 1.3d48.3 ± 0.6a
Collagen surface density (%)7.0 ± 1.1c6.2 ± 1.7c12.3 ± 2.0c2.6 ± 0.7c17.4 ± 5.6
Hyaluronate (ng/mL)63 ± 25d87 ± 28d47 ± 25d56 ± 16d783 ± 111
Table 3 Histologic fibrosis staging and grading of necroinflammatory activity scores according to Scheuer system at the end of the study (mean ± SE)
parameterVit CVit EVit ECShamControl
Stage3.2 ± 0.4b2.5 ± 0.5b2.4 ± 0.8ab0.5 ± 0.53.1 ± 0.7b
Grade1.5 ± 0.5d1.5 ± 0.5d1.4 ± 0.5d0.2 ± 0.41.9 ± 0.7f
Table 4 Correlation of serum hyaluronate with histologic fibrosis staging, collagen surface density and biochemical collagen content
Fibrosis stageCollagen densityCollagen content
Serumr+ 0.38+ 0.56+ 0.71
HyaluronateP <0.0250.0050.0001